These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6429673)

  • 1. Salicylate:aspirin ratios: relevance to aspirin's antithrombotic action.
    Philp RB; O'Kruk RJ; Paul ML
    Prostaglandins Leukot Med; 1984 May; 14(2):287-8. PubMed ID: 6429673
    [No Abstract]   [Full Text] [Related]  

  • 2. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
    Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
    J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.
    Higgs GA; Salmon JA; Henderson B; Vane JR
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1417-20. PubMed ID: 3103135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of aspirin and sodium salicylate.
    Amann R; Peskar BA
    Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin: plasma concentration and effects.
    Thiessen JJ
    Thromb Res Suppl; 1983; 4():105-11. PubMed ID: 6356461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
    de Gaetano G; Cerletti C; Dejana E; Latini R
    Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase.
    Rizk M; Abdel-Rahman MS
    Prostaglandins Leukot Essent Fatty Acids; 1994 Nov; 51(5):363-7. PubMed ID: 7846108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia.
    Kuhn W; Müller T; Bttner T; Gerlach M
    Stroke; 1995 Oct; 26(10):1959-60. PubMed ID: 7570757
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the inhibitory effects of acetylsalicylic acid and trifusal on enzymes related to thrombosis.
    Garcia Rafanell J; Planas JM; Puig-Parellada P
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):343-50. PubMed ID: 226020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aspirin and salicylate on LDL oxidation in vitro.
    Bolton CH; Dwight J; Hopton MI; Steer K; Hartog M
    Biochem Soc Trans; 1997 Aug; 25(3):521S. PubMed ID: 9388737
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of action: aspirin.
    Hoak JC
    Thromb Res Suppl; 1983; 4():47-51. PubMed ID: 6415858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Dachineni R; Kumar DR; Callegari E; Kesharwani SS; Sankaranarayanan R; Seefeldt T; Tummala H; Bhat GJ
    Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans.
    Morris HG; Sherman NA; McQuain C; Goldlust MB; Chang SF; Harrison LI
    Ther Drug Monit; 1985; 7(4):435-8. PubMed ID: 3866409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
    Ali M; McDonald JW
    Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts.
    Farivar RS; Chobanian AV; Brecher P
    Circ Res; 1996 May; 78(5):759-68. PubMed ID: 8620595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase.
    Rao GH; Reddy KR; White JG
    Prostaglandins Leukot Med; 1982 Jul; 9(1):109-15. PubMed ID: 6813873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zomepirac--aspirin interactions in man.
    Desiraju RK; Nayak RK; Pritchard JF
    J Clin Pharmacol; 1984; 24(8-9):371-80. PubMed ID: 6480878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective.
    Cordeiro RS; Silva PM; Martins MA; Vargaftig BB
    Prostaglandins; 1986 Nov; 32(5):719-27. PubMed ID: 3103172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.